What the Latest Findings Say About Dexamethasone

A study published in the New England Journal of Medicine reports that among people hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day risk of death for people who were receiving either invasive mechanical ventilation or oxygen alone at randomization. However, the drug did not show a benefit for people receiving no respiratory support.

The study observed around 2,100 people hospitalized for Covid-19. A portion of the group was randomly assigned to receive 10 days’ worth of dexamethasone combined with their standard care…

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store